Genetic testing in patients with early-onset atrial fibrillation (AFib or AF) can identify variants associated with more serious cardiomyopathy and arrhythmia syndromes that may otherwise remain undiagnosed, according to a Vanderbilt-led study recently published in JAMA Cardiology.
Lewis Lefkowitz, MD, professor of Preventive Medicine, emeritus, whose dedication to health equity and underserved communities helped thousands of patients and influenced generations of Vanderbilt medical students, died Sept. 26. He was 90.
New research from Vanderbilt-Ingram Cancer Center provides insight into how genetic variants convey breast cancer susceptibility by altering the transcription factor proteins that convert DNA strands into RNA.
A clinical trial has been launched to test a new targeted therapy in patients with advanced and difficult-to-treat cancers.
Vanderbilt epidemiologists conducted in-depth whole genome sequencing of breast cancer risk genes in Black women, who die at higher rates and have more aggressive disease, to discover mutations that may improve testing and treatment selection.
Vanderbilt research found that a novel immunotherapy demonstrated robust effectiveness in treating relapsed or refractory multiple myeloma.
Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients
Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory…